N-glycosylation of CD4+ T cell changes with the development in Graves' disease and is sensitive to methimazole treatment

Sara Trzos(Jagiellonian University), Ewa Pocheć(Jagiellonian University)

Biochimica et Biophysica Acta (BBA) - General Subjects

May 25, 2025

10.1016/j.bbagen.2025.130824

Cited by 0

Related Papers

Riboflavin Reduces Pro-Inflammatory Activation of Adipocyte-Macrophage Co-culture. Potential Application of Vitamin B2 Enrichment for Attenuation of Insulin Resistance and Metabolic Syndrome Development

|Molecules|2016|51

Changes of IgG N-Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves’ Disease and the Association With the Severity of Inflammation in Hashimoto’s Thyroiditis

|Frontiers in Immunology|2022|22

Cytotoxic and Antioxidant Activity of Hypericum perforatum L. Extracts against Human Melanoma Cells from Different Stages of Cancer Progression, Cultured under Normoxia and Hypoxia

|Molecules|2023|17

The diverse N-glycosylation profiles of CD4+CD25- and CD4+CD25+ T cells in Hashimoto’s thyroiditis

|Frontiers in Immunology|2025|1

Swainsonine Protects Human Thyrocytes from Fas-Induced Apoptosis: In vitro Study on Nthy-Ori 3-1 Cell Line

|Journal of Inflammation Research|2025|0